INVIVYD INC (IVVD:NASDAQ)
$0.99 -0.03 (-2.9412%)
Analysed INVIVYD INC (IVVD:NASDAQ) News Sources
Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates
14-05-2026
yahoo.com
Invivyd Q1 Earnings Call Highlights
14-05-2026
marketbeat.com
Invivyd Inc (IVVD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments
14-05-2026
yahoo.com
Invivyd (IVVD): 10 Best NASDAQ Stocks Under $5 to Buy Right Now
18-05-2026
yahoo.com
Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
01-06-2026
yahoo.com
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03-06-2026
yahoo.com
This Invivyd Insider Increased Their Holding In The Last Year
06-06-2026
yahoo.com
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration
09-06-2026
yahoo.com
Invivyd Doses First Participants in Phase 3 Trial of COVID-19 Antibody VYD2311
09-06-2026
yahoo.com
Invivyd doses first participants in Phase 3 COVID-19 trial
09-06-2026
proactiveinvestors.com
What is the current price of INVIVYD INC (IVVD:NASDAQ)?
The current price of INVIVYD INC (IVVD:NASDAQ) is $0.99.
INVIVYD INC (IVVD:NASDAQ) absolute price change since previous trading day?
The absolute price change of INVIVYD INC (IVVD:NASDAQ) since the previous trading day is $-0.03.
INVIVYD INC (IVVD:NASDAQ) percentage price change since previous trading day?
The percentage price change of INVIVYD INC (IVVD:NASDAQ) since the previous trading day is -2.9412%.
What is the most recent average sentiment score for INVIVYD INC (IVVD:NASDAQ)?
The most recent average sentiment score for INVIVYD INC (IVVD:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for INVIVYD INC (IVVD:NASDAQ)?
The most recent sentiment for INVIVYD INC (IVVD:NASDAQ) is .
SEC-8K** Filing Available For INVIVYD INC (IVVD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.